211
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

On the search for COVID-19 therapeutics: identification of potential SARS-CoV-2 main protease inhibitors by virtual screening, pharmacophore modeling and molecular dynamics

&
Pages 7815-7828 | Received 09 Jan 2021, Accepted 06 Mar 2021, Published online: 22 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shafi Mahmud, Mohasana Akter Mita, Suvro Biswas, Gobindo Kumar Paul, Maria Meha Promi, Shamima Afrose, Robiul Hasan, Sharmin Sultana Shimu, Shahriar Zaman, Salah Uddin, Trina Ekawati Tallei, Talha Bin Emran & Abu Saleh. (2021) Molecular docking and dynamics study to explore phytochemical ligand molecules against the main protease of SARS-CoV-2 from extensive phytochemical datasets. Expert Review of Clinical Pharmacology 14:10, pages 1305-1315.
Read now

Articles from other publishers (4)

Cuong Quoc Duong & Phuong Thuy Viet Nguyen. (2023) Exploration of SARS-CoV-2 Mpro Noncovalent Natural Inhibitors Using Structure-Based Approaches. ACS Omega 8:7, pages 6679-6688.
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Luis Heriberto Vázquez-Mendoza, Humberto L. Mendoza-Figueroa, Juan Benjamín García-Vázquez, José Correa-Basurto & Jazmín García-Machorro. (2022) In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking. International Journal of Molecular Sciences 23:7, pages 3987.
Crossref
Amr El-Demerdash, Afnan Hassan, Tarek Mohamed Abd El-Aziz, James D. Stockand & Reem K. Arafa. (2021) Marine Brominated Tyrosine Alkaloids as Promising Inhibitors of SARS-CoV-2. Molecules 26:20, pages 6171.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.